{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:33:44Z","timestamp":1790624024931,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01HL146442"],"award-info":[{"award-number":["R01HL146442"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01HL148151"],"award-info":[{"award-number":["R01HL148151"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01HL149714"],"award-info":[{"award-number":["R01HL149714"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01HL161004"],"award-info":[{"award-number":["R01HL161004"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["RM1GM131968"],"award-info":[{"award-number":["RM1GM131968"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["HL152961"],"award-info":[{"award-number":["HL152961"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000850","name":"National Heart and Lung Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH1910259"],"award-info":[{"award-number":["W81XWH1910259"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2010249"],"award-info":[{"award-number":["W81XWH2010249"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.vph.2023.107157","type":"journal-article","created":{"date-parts":[[2023,2,26]],"date-time":"2023-02-26T12:36:18Z","timestamp":1677414978000},"page":"107157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Histone deacetylase inhibitors synergize with sildenafil to suppress purine metabolism and proliferation in pulmonary hypertension"],"prefix":"10.1016","volume":"149","author":[{"given":"Hui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"D'Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Reisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzette","family":"Riddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Muralidhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Bull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia","family":"Gerasimovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt R.","family":"Stenmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vph.2023.107157_bb0005","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1183\/09031936.00057010","article-title":"French pulmonary arterial hypertension, survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension","volume":"36","author":"Humbert","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.vph.2023.107157_bb0010","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.003973","article-title":"Increasing incidence and prevalence of World Health Organization groups 1 to 4 pulmonary hypertension: a population-based cohort study in Ontario, Canada","volume":"11","author":"Wijeratne","year":"2018","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.vph.2023.107157_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autneu.2015.05.006","article-title":"Purinergic signalling and the autonomic nervous system in health and disease","volume":"191","author":"Burnstock","year":"2015","journal-title":"Auton. Neurosci."},{"issue":"1","key":"10.1016\/j.vph.2023.107157_bb0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/CIRCRESAHA.116.309726","article-title":"Purinergic signaling in the cardiovascular system","volume":"120","author":"Burnstock","year":"2017","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.vph.2023.107157_bb0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pharmthera.2013.06.002","article-title":"Cardiovascular adenosine receptors: expression, actions and interactions","volume":"140","author":"Headrick","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"18","key":"10.1016\/j.vph.2023.107157_bb0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017404","article-title":"Purinergic dysfunction in pulmonary arterial hypertension","volume":"9","author":"Cai","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"19","key":"10.1016\/j.vph.2023.107157_bb0035","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/CIRCULATIONAHA.121.058901","article-title":"ATIC-associated De Novo purine synthesis is critically involved in proliferative arterial disease","volume":"146","author":"Ma","year":"2022","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.vph.2023.107157_bb0040","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1111\/bph.14205","article-title":"PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery","volume":"175","author":"Andersson","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.vph.2023.107157_bb0045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/vhrm.2006.2.4.411","article-title":"Sildenafil in the treatment of pulmonary hypertension","volume":"2","author":"Barnett","year":"2006","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.vph.2023.107157_bb0050","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.12688\/f1000research.9739.1","article-title":"Recent advances in the management of pulmonary arterial hypertension","volume":"5","author":"Tsai","year":"2016","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.vph.2023.107157_bb0055","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1124\/mol.107.040212","article-title":"Conformational variations of both phosphodiesterase-5 and inhibitors provide the structural basis for the physiological effects of vardenafil and sildenafil","volume":"73","author":"Wang","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"20","key":"10.1016\/j.vph.2023.107157_bb0060","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil use in pulmonary arterial hypertension study, sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.vph.2023.107157_bb0065","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1450","article-title":"Pulmonary hypertension therapy and a systematic review of efficacy and safety of PDE-5 inhibitors","volume":"139","author":"Unegbu","year":"2017","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.vph.2023.107157_bb0070","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0025-6196(12)62055-2","article-title":"Vasodilator therapy for primary pulmonary hypertension","volume":"59","author":"McGoon","year":"1984","journal-title":"Mayo Clin. Proc."},{"issue":"23","key":"10.1016\/j.vph.2023.107157_bb0075","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.vph.2023.107157_bb0080","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01887-2018","article-title":"Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives","volume":"53","author":"Humbert","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.vph.2023.107157_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011343","article-title":"Repurposing medications for treatment of pulmonary arterial hypertension: What\u2019s old is new again","volume":"8","author":"Prins","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.vph.2023.107157_bb0090","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00441-016-2539-y","article-title":"Pulmonary vascular remodeling in pulmonary hypertension","volume":"367","author":"Tuder","year":"2017","journal-title":"Cell Tissue Res."},{"issue":"3","key":"10.1016\/j.vph.2023.107157_bb0095","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1089\/ars.2017.7217","article-title":"Hallmarks of pulmonary hypertension: mesenchymal and inflammatory cell metabolic reprogramming","volume":"28","author":"D\u2019Alessandro","year":"2018","journal-title":"Antioxid. Redox Signal."},{"issue":"15","key":"10.1016\/j.vph.2023.107157_bb0100","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1161\/CIRCULATIONAHA.116.023171","article-title":"Metabolic reprogramming regulates the proliferative and inflammatory phenotype of adventitial fibroblasts in pulmonary hypertension through the transcriptional corepressor C-terminal binding Protein-1","volume":"134","author":"Li","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.vph.2023.107157_bb0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1165\/rcmb.2015-0142OC","article-title":"Constitutive reprogramming of fibroblast mitochondrial metabolism in pulmonary hypertension","volume":"55","author":"Plecita-Hlavata","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"8","key":"10.1016\/j.vph.2023.107157_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22083852","article-title":"Mechanisms contributing to the dysregulation of miRNA-124 in pulmonary hypertension","volume":"22","author":"Zhang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"25","key":"10.1016\/j.vph.2023.107157_bb0115","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1161\/CIRCULATIONAHA.117.028069","article-title":"Metabolic and proliferative state of vascular adventitial fibroblasts in pulmonary hypertension is regulated through a MicroRNA-124\/PTBP1 (Polypyrimidine tract binding protein 1)\/pyruvate kinase muscle Axis","volume":"136","author":"Zhang","year":"2017","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.vph.2023.107157_bb0120","first-page":"L773","article-title":"Hypoxic activation of glucose-6-phosphate dehydrogenase controls the expression of genes involved in the pathogenesis of pulmonary hypertension through the regulation of DNA methylation","volume":"318","author":"Joshi","year":"2020","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"2","key":"10.1016\/j.vph.2023.107157_bb0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tibs.2016.09.009","article-title":"A new view into the regulation of purine metabolism: the Purinosome","volume":"42","author":"Pedley","year":"2017","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.vph.2023.107157_bb0130","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","article-title":"From purines to purinergic signalling: molecular functions and human diseases","volume":"6","author":"Huang","year":"2021","journal-title":"Signal. Transduct. Target Ther."},{"issue":"7","key":"10.1016\/j.vph.2023.107157_bb0135","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1021\/cr900028p","article-title":"Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer","volume":"109","author":"Parker","year":"2009","journal-title":"Chem. Rev."},{"issue":"8","key":"10.1016\/j.vph.2023.107157_bb0140","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ctrv.2013.03.006","article-title":"Older and new purine nucleoside analogs for patients with acute leukemias","volume":"39","author":"Robak","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.vph.2023.107157_bb0145","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3389\/fimmu.2018.01697","article-title":"Potential mechanisms connecting purine metabolism and cancer therapy","volume":"9","author":"Yin","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.vph.2023.107157_bb0150","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1365-2141.2003.04336.x","article-title":"Mechanism of action of purine analogues in chronic lymphocytic leukaemia","volume":"121","author":"Pettitt","year":"2003","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.vph.2023.107157_bb0155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCRESAHA.114.301633","article-title":"MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts","volume":"114","author":"Wang","year":"2014","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.vph.2023.107157_bb0160","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/rcm.7834","article-title":"A three-minute method for high-throughput quantitative metabolomics and quantitative tracing experiments of central carbon and nitrogen pathways","volume":"31","author":"Nemkov","year":"2017","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"W1","key":"10.1016\/j.vph.2023.107157_bb0165","doi-asserted-by":"crossref","first-page":"W251","DOI":"10.1093\/nar\/gkv380","article-title":"MetaboAnalyst 3.0--making metabolomics more meaningful","volume":"43","author":"Xia","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"Suppl. 1","key":"10.1016\/j.vph.2023.107157_bb0170","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/sj.ijir.3901205","article-title":"Mechanisms of action of PDE5 inhibition in erectile dysfunction","volume":"16","author":"Corbin","year":"2004","journal-title":"Int. J. Impot. Res."},{"issue":"21","key":"10.1016\/j.vph.2023.107157_bb0175","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.148382","article-title":"Complement-containing small extracellular vesicles from adventitial fibroblasts induce pro-inflammatory and metabolic reprogramming in macrophages","volume":"6","author":"Kumar","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.vph.2023.107157_bb0180","article-title":"Microenvironmental regulation of macrophage transcriptomic and metabolomic profiles in pulmonary hypertension","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vph.2023.107157_bb0185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-3-319-63245-2_14","article-title":"Metabolic reprogramming and redox signaling in pulmonary hypertension","volume":"967","author":"Plecit\u00e1-Hlavat\u00e1","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.vph.2023.107157_bb0190","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3892\/ol.2016.4168","article-title":"PKM2 and cancer: the function of PKM2 beyond glycolysis","volume":"11","author":"Dong","year":"2016","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.vph.2023.107157_bb0195","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.molcel.2015.12.014","article-title":"Serine metabolism supports the methionine cycle and DNA\/RNA methylation through De novo ATP synthesis in cancer cells","volume":"61","author":"Maddocks","year":"2016","journal-title":"Mol. Cell"},{"issue":"7424","key":"10.1016\/j.vph.2023.107157_bb0200","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nature11540","article-title":"Serine is a natural ligand and allosteric activator of pyruvate kinase M2","volume":"491","author":"Chaneton","year":"2012","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.vph.2023.107157_bb0205","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1161\/CIRCULATIONAHA.117.028034","article-title":"Identification of MicroRNA-124 as a major regulator of enhanced endothelial cell glycolysis in pulmonary arterial hypertension via PTBP1 (polypyrimidine tract binding protein) and pyruvate kinase M2","volume":"136","author":"Caruso","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.vph.2023.107157_bb0210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.vph.2023.107157_bb0215","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s42255-018-0014-7","article-title":"Coupling Krebs cycle metabolites to signalling in immunity and cancer","volume":"1","author":"Ryan","year":"2019","journal-title":"Nat. Metab."},{"issue":"2","key":"10.1016\/j.vph.2023.107157_bb0220","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.ijir.3900354","article-title":"Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction","volume":"10","author":"Morales","year":"1998","journal-title":"Int. J. Impot. Res."},{"issue":"8","key":"10.1016\/j.vph.2023.107157_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160505","article-title":"New biochemical insights into the mechanisms of pulmonary arterial hypertension in humans","volume":"11","author":"Bujak","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.vph.2023.107157_bb0230","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/CIRCULATIONAHA.116.024602","article-title":"Plasma metabolomics implicates modified transfer RNAs and altered bioenergetics in the outcomes of pulmonary arterial hypertension","volume":"135","author":"Rhodes","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.vph.2023.107157_bb0235","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/HYPERTENSIONAHA.120.14772","article-title":"CRISPR-mediated single nucleotide polymorphism modeling in rats reveals insight into reduced cardiovascular risk associated with Mediterranean G6PD variant","volume":"76","author":"Kitagawa","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.vph.2023.107157_bb0240","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0021-9150(99)00041-6","article-title":"Nitric oxide inhibits proliferation of human endothelial cells via a mechanism independent of cGMP","volume":"144","author":"Heller","year":"1999","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.vph.2023.107157_bb0245","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/01.CIR.95.5.1269","article-title":"cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway","volume":"95","author":"Yu","year":"1997","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.vph.2023.107157_bb0250","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11302-016-9509-4","article-title":"Guanosine and its role in neuropathologies","volume":"12","author":"Bettio","year":"2016","journal-title":"Purinergic Signal"},{"issue":"11","key":"10.1016\/j.vph.2023.107157_bb0255","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1073\/pnas.70.11.3250","article-title":"Role of guanine nucleotides in protein synthesis. Elongation factor G and guanosine 5\u2032-triphosphate,3\u2032-diphosphate","volume":"70","author":"Hamel","year":"1973","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2023.107157_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-152832-4.50003-3","article-title":"The role of GTP-binding proteins in signal transduction: from the sublimely simple to the conceptually complex","volume":"32","author":"Rodbell","year":"1992","journal-title":"Curr. Top. Cell. Regul."},{"issue":"1","key":"10.1016\/j.vph.2023.107157_bb0265","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2302\/kjm.65-001-ABST","article-title":"Dynamic role of the GTP energy metabolism in cancers","volume":"65","author":"Sasaki","year":"2016","journal-title":"Keio J. Med."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189123000174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189123000174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:21:26Z","timestamp":1761528086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189123000174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":53,"alternative-id":["S1537189123000174"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2023.107157","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone deacetylase inhibitors synergize with sildenafil to suppress purine metabolism and proliferation in pulmonary hypertension","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2023.107157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107157"}}